Literature DB >> 25188458

Natural history, presentation, and diagnosis of hidradenitis suppurativa.

Robert G Micheletti1.   

Abstract

The diagnosis of hidradenitis suppurativa (HS) is based on a characteristic history and physical exam. The anatomic sites of involvement include the axillae (most common), groin, and buttocks, and the perianal, perineal, and mammary regions. Initially, HS manifests with open comedones (usually with two or more "heads") and tender subcutaneous acneiform papules. Without intervention, the natural history of HS is chronic and progressive. More painful subcutaneous nodules form, which rupture and drain a thick, mucopurulent, foul-smelling fluid. Later, sinus tracts form, and, over time, ropelike fibrotic subcutaneous scarring occurs, which can lead to disabling contractures of the affected limbs. Clinically, the severity of disease is classified using the Hurley staging system, which provides guidance for choosing among treatment options. 2014 published by Frontline Medical Communications.

Entities:  

Keywords:  Hurley staging system; Sartorius staging system; follicular occlusion; hidradenitis suppurativa

Mesh:

Year:  2014        PMID: 25188458     DOI: 10.12788/j.sder.0092

Source DB:  PubMed          Journal:  Semin Cutan Med Surg        ISSN: 1085-5629


  5 in total

1.  Clinical manifestations and quality of life in hidradenitis suppurativa patients: survey of participants from an internet support group.

Authors:  Isabel Greco Tavora; Gabriela Cabral Bissoli; Hélio Amante Miot; Juliano Vilaverde Schmitt
Journal:  An Bras Dermatol       Date:  2019-07-29       Impact factor: 1.896

2.  Diagnosis and management of hidradenitis suppurativa in women.

Authors:  Erin K Collier; Ram K Parvataneni; Michelle A Lowes; Haley B Naik; Martin Okun; Vivian Y Shi; Jennifer L Hsiao
Journal:  Am J Obstet Gynecol       Date:  2020-09-24       Impact factor: 8.661

3.  Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data.

Authors:  John W Frew; Caroline S Jiang; Neha Singh; David Grand; Kristina Navrazhina; Roger Vaughan; James G Krueger
Journal:  J Am Acad Dermatol       Date:  2019-12-24       Impact factor: 11.527

Review 4.  Spotlight on adalimumab in the treatment of active moderate-to-severe hidradenitis suppurativa.

Authors:  Christina Fotiadou; Efstratios Vakirlis; Dimitrios Ioannides
Journal:  Clin Cosmet Investig Dermatol       Date:  2016-10-19

5.  Immunopathogenesis of hidradenitis suppurativa and response to anti-TNF-α therapy.

Authors:  Margaret M Lowe; Haley B Naik; Sean Clancy; Mariela Pauli; Kathleen M Smith; Yingtao Bi; Robert Dunstan; Johann E Gudjonsson; Maia Paul; Hobart Harris; Esther Kim; Uk Sok Shin; Richard Ahn; Wilson Liao; Scott L Hansen; Michael D Rosenblum
Journal:  JCI Insight       Date:  2020-10-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.